Evidence map›Paper›PMID 28643116›Full record

ReviewCurrent genetics2018

Express yourself: how PP2A-B55

Ruth Martín, Sandra Lopez-Aviles

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ruth MartínCentre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Gaustadalleen 21, 0349, Oslo, Norway.
Sandra Lopez-AvilesCentre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo, Gaustadalleen 21, 0349, Oslo, Norway. sandra.lopez-aviles@ncmm.uio.no.ORCID http://orcid.org/0000-0002-0498-1331
University of Oslo · NO

Funding

Norwegian Cancer Society 5843744Research Council of Norway FRIMEDBIO 214049
6 · The paper itself

Abstract

The control of cell fate, growth and proliferation in response to nitrogen availability is a tightly controlled process, with the two TOR complexes (TORC1 and TORC2) and their effectors playing a central role. PP2A-B55

Indexed as

Gene Expression Regulation, FungalMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2NitrogenPhosphoprotein PhosphatasesPoly(A)-Binding ProteinsProtein BindingProtein Serine-Threonine KinasesSchizosaccharomycesSchizosaccharomyces pombe ProteinsSignal TransductionStructure-Activity RelationshipGad8 protein, S pombeMechanistic Target of Rapamycin Complex 1Mechanistic Target of Rapamycin Complex 2NitrogenPhosphoprotein PhosphatasesPoly(A)-Binding ProteinsProtein Serine-Threonine KinasesSchizosaccharomyces pombe ProteinsDifferentiationGad8Nitrogen signalingPP2A-B55TORC1TORC2

Identifiers

PMID28643116
PMCPMC5778150
OpenAlexW2665811274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.